An Inception Cohort Study Assessing the Role of Pneumococcal and other Bacterial Pathogens in Children with Influenza and ILI and a Clinical Decision Model for Stringent Antibiotic Use

Abstract

Background

Influenza-like illness (ILI) is a common reason for paediatric consultations. Viral causes predominate, but antibiotics are used frequently. With regard to influenza, pneumococcal coinfections are considered major contributors to morbidity/mortality.

Methods

In the context of a perennial quality management (QM) programme at the Charité Departments of Paediatrics and Microbiology in collaboration with the Robert Koch Institute, children aged 0–18 years presenting with signs and symptoms of ILI were followed from the time of initial presentation until hospital discharge (Charité Influenza-Like Disease = ChILD Cohort). An independent QM team performed highly standardized clinical assessments using a disease severity score based on World Health Organization criteria for uncomplicated and complicated/progressive disease. Nasopharyngeal and pharyngeal samples were collected for viral reverse transcription polymerase chain reaction and bacterial culture/sensitivity and MaldiTOF analyses. The term ‘detection’ was used to denote any evidence of viral or bacterial pathogens in the (naso)pharyngeal cavity. With the ChILD Cohort data collected, a standard operating procedure (SOP) was created as a model system to reduce the inappropriate use of antibiotics in children with ILI. Monte Carlo simulations were performed to assess cost-effectiveness.

Results

Among 2,569 ChILD Cohort patients enrolled from 12/2010 to 04/2013 (55% male, mean age 3.2 years, range 0–18, 19% >5 years), 411 patients showed laboratory-confirmed influenza, with bacterial co-detection in 35%. Influenza and pneumococcus were detected simultaneously in 12/2,569 patients, with disease severity clearly below average. Pneumococcal vaccination rates were close to 90%. Nonetheless, every fifth patient was already on antibiotics upon presentation; new antibiotic prescriptions were issued in an additional 20%. Simulation of the model SOP in the same dataset revealed that the proposed decision model could have reduced the inappropriate use of antibiotics significantly (P≤0.01) with an incremental cost-effectiveness ratio of -99.55€.

Conclusions

Physicians should be made aware that in times of pneumococcal vaccination the prevalence and severity of influenza infections complicated by pneumococci may decline. Microbiological testing in combination with standardized disease severity assessments and review of vaccination records could be cost-effective, as well as promoting stringent use of antibiotics and a personalized approach to managing children with ILI.

References

Tregoning

J.S.

, Schwarze

Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.

Clin Microbiol Rev 2010; 23: 74–98.

Chonmaitree

, Revai

, Grady

J.J.

Viral upper respiratory tract infection and otitis media complication in young children.

Clin Infect Dis 2008; 46: 815–823.

Lautenbach

, Metlay

J.P.

Managing upper respiratory tract infections: practice without evidence.

J Gen Intern Med 1999; 14: 203–204.

Pavia

A.T.

Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis.

Clin Infect Dis 2011; 52 Suppl 4: S284–S289.

Nyquist

A.C.

, Gonzales

, Steiner

J.F.

Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis.

JAMA 1998; 279: 875–877.

Koller

, Hoffmann

, Maier

Variation in antibiotic prescriptions: is area deprivation an explanation? Analysis of 1.2 million children in Germany.

Infection 2013; 41: 121–127.

Holstiege

, Garbe

Systemic antibiotic use among children and adolescents in Germany: a population-based study.

Eur J Pediatr 2013; 172: 787–795.

Morens

D.M.

, Taubenberger

J.K.

, Fauci

A.S.

Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness.

J Infect Dis 2008; 198: 962–970.

Williams

D.J.

, Hall

, Brogan

T.V.

Influenza coinfection and outcomes in children with complicated pneumonia.

Arch Pediatr Adolesc Med 2011; 165: 506–512.

10.

Cillóniz

, Ewig

, Menendez

Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia.

J Infect 2012; 65: 223–230.

11.

Rath

, Tief

, Karsch

Towards a personalised approach to managing influenza infections in infants and children - food for thought and a note on oseltamivir.

Infect Disord Drug Targets 2013; 13: 25–33.

12.

Rath

, Tief

, Obermeier

Early detection of influenza A and B infection in infants and children using conventional and fluorescence-based rapid testing.

J Clin Virol 2012; 55: 329–333.

13.

Rath

, von Kleist

, Tief

Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with influenza A(H1N1) 2009 and influenza B viruses.

Pediatr Infect Dis J 2012; 31: 899–905.

14.

Chen

, Pouran Yousef

, Duwe

Quantitative influenza follow-up testing (QIFT)–a novel biomarker for the monitoring of disease activity at the point-of-care.

PLoS ONE 2014; 9: e92500.

15.

WHO. Clinical management of human infection with pandemic (H1N1) 2009: revised guidance [Global Alert and Response]. (Accessed 6 July 2014.) Available from http://www.who.int/csr/resources/publications/swineflu/clinical_management_h1n1.pdf.

16.

Principi

, Terranova

, Zampiero

Pharyngeal colonization by Streptococcus pneumoniae in older children and adolescents in a geographical area characterized by relatively limited pneumococcal vaccination coverage.

Pediatr Infect Dis J 2015; 34: 426–432.

17.

Blossom

D.B.

, Namayanja-Kaye

, Nankya-Mutyoba

Oropharyngeal colonization by Streptococcus pneumoniae among HIV-infected adults in Uganda: assessing prevalence and antimicrobial susceptibility.

Int J Infect Dis 2006; 10: 458–464.

18.

Gritzfeld

J.F.

, Roberts

, Roche

Comparison between nasopharyngeal swab and nasal wash, using culture and PCR, in the detection of potential respiratory pathogens.

BMC Res Notes 2011; 4: 122.

19.

Newman

Microbiology in pictures - Streptococcus pneumoniae. (Accessed 1 December 2015.) Available from http://www.microbiologyinpictures.com/streptococcuspneumoniae.html.

20.

Adegbola

R.A.

, DeAntonio

, Hill

P.C.

Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis.

PLoS ONE 2014; 9: e103293.

21.

Principi

, Lughetti

, Cappa

Streptococcus pneumoniae oropharyngeal colonization in school-age children and adolescents with type 1 diabetes mellitus: impact of the heptavalent pneumococcal conjugate vaccine.

Hum Vaccin Immunother 2016; 12: 293–300.

22.

von Elm

, Altman

D.G.

, Egger

Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies.

BMJ 2007; 335: 806–808.

23.

Reiche

, Schweiger

Genetic variability of group A human respiratory syncytial virus strains circulating in Germany from 1998 to 2007.

J Clin Microbiol 2009; 47: 1800–1810.

24.

Schulze

, Nitsche

, Schweiger

Diagnostic approach for the differentiation of the pandemic influenza A(H1N1)v virus from recent human influenza viruses by real-time PCR.

PLoS ONE 2010; 5: e9966.

25.

Chmielewicz

, Nitsche

, Schweiger

Development of a PCR-based assay for detection, quantification, and genotyping of human adenoviruses.

Clin Chem 2005; 51: 1365–1373.

26.

Reiche

, Jacobsen

, Neubauer

Human metapneumovirus: insights from a ten-year molecular and epidemiological analysis in Germany.

PLoS ONE 2014; 9: e88342.

27.

IFAP. Service Institute for Physicians and Pharmacists Inc.: Arzneimittel aktuell 2015. (Accessed 6 July 2014.) Available from http://medikamente.ifap.de/.

28.

Høye

, Frich

J.C.

, Lindbæk

Use and feasibility of delayed prescribing for respiratory tract infections: a questionnaire survey.

BMC Fam Pract 2011; 12: 34.

29.

Cohen

Statistical power analysis for the behavioral sciences (2nd ed.). Mahwah, NJ: Lawrence Erlbaum Assoc Inc, 1988.

30.

Kullback

Letter to the Editor: The Kullback–Leibler distance.

The American Statistician 1987; 41: 2.

31.

Tibshirani

Regression shrinkage and selection via the Lasso.

J R Stat Soc Series B Stat Methodol 1996; 58: 267–288.

32.

Chertow

D.S.

, Memoli

M.J.

Bacterial coinfection in influenza: a grand rounds review.

JAMA 2013; 309: 275–282.

33.

van der Linden

, Weiss

, Falkenhorst

Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.

Vaccine 2012; 30: 5880–5885.

34.

Feikin

D.R.

, Kagucia

E.W.

, Loo

J.D.

Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.

PLoS Med 2013; 10: e1001517.

35.

Afonso

E.T.

, Minamisava

, Bierrenbach

A.L.

Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil.

Emerg Infect Dis 2013; 19: 589–597.

36.

Streng

, Grote

, Liese

J.G.

Severe influenza cases in paediatric intensive care units in Germany during the pre-pandemic seasons 2005 to 2008.

BMC Infect Dis 2011; 11: 233.

37.

Reed

, Madhi

S.A.

, Klugman

K.P.

Development of the Respiratory Index of Severity in Children (RISC) score among young children with respiratory infections in South Africa.

PLoS ONE 2012; 7: e27793.

38.

Launes

, de-Sevilla

M.F.

, Selva

Viral coinfection in children less than five years old with invasive pneumococcal disease.

Pediatr Infect Dis J 2012; 31: 650–653.

39.

Hsiao

H.J.

, Wu

C.T.

, Huang

J.L.

Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit.

BMC Pediatr 2015; 15: 85.

40.

Weil-Olivier

, van der Linden

, de Schutter

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

BMC Infect Dis 2012; 12: 207.

41.

Desai

A.P.

, Sharma

, Crispell

E.K.

Decline in Pneumococcal nasopharyngeal carriage of vaccine serotypes after the introduction of the 13-valent Pneumococcal conjugate vaccine in children in Atlanta, Georgia.

Pediatr Infect Dis J 2015; 34: 1168–1174.

42.

Navarro Torné

, Dias

J.G.

, Quinten

European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era.

Vaccine 2014; 32: 3644–3650.

43.

Skovbjerg

, Soderstrom

, Hynsjo

Low rate of pneumococci non-susceptible to penicillin in healthy Swedish toddlers.

Scand J Infect Dis 2013; 45: 279–284.

44.

Cohen

, Bingen

, Levy

[Antibiotic resistance of pneumococci and H. influenzae isolated from the nasopharyngeal flora of children with acute otitis media between 2006 and 2010].

Archives de pediatrie 2011; 18: 926–931. French.

45.

Epidemiologisches Bulletin RKI. [Recommendations by the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute (RKI)/issued August 2013]. German. (Updated 26 August 2013. Accessed 26 August 2013.) Available from http://bundesaerztekammer.de/downloads/STIKOEmpf2013.pdf.

46.

Wiese-Posselt

, Tertilt

, Zepp

Vaccination recommendations for Germany.

Dtsch Arztebl Int 2011; 108: 771–779, quiz 80.

47.

Blank

P.R.

, Bonnelye

, Ducastel

Attitudes of the general public and general practitioners in five countries towards pandemic and seasonal influenza vaccines during season 2009/2010.

PLoS ONE 2012; 7: e45450.

48.

Cecinati

, Esposito

, Scicchitano

Effectiveness of recall systems for improving influenza vaccination coverage in children with oncohematological malignancies.

Hum Vaccin 2010; 6: 194–197.

49.

Esposito

, Marchisio

, Droghetti

Influenza vaccination coverage among children with high-risk medical conditions.

Vaccine 2006; 24: 5251–5255.

50.

Hoffmann

, van Bijnen

E.M.

, George

Associations between the prevalence of influenza vaccination and patient's knowledge about antibiotics: a cross-sectional study in the framework of the APRES-project in Austria.

BMC Public Health 2015; 15: 981.

51.

Fiore

A.E.

, Fry

, Shay

Antiviral agents for the treatment and chemoprophylaxis of influenza – recommendations of the Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep 2011; 60: 1–24.

52.

Myles

P.R.

, Semple

M.G.

, Lim

W.S.

Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK.

Thorax 2012; 67: 709–717.

53.

Gray

B.M.

, Converse

G.M.

III , Dillon

H.C.

Jr. . Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980; 142: 923–933.

54.

Masters

P.L.

, Brumfitt

, Mendez

R.L.

Bacterial flora of the upper respiratory tract in Paddington families, 1952-4.

BMJ 1958; 1: 1200–1205.

55.

Watt

J.P.

, O'Brien

K.L.

, Katz

Nasopharyngeal versus oropharyngeal sampling for detection of pneumococcal carriage in adults.

J Clin Microbiol 2004; 42: 4974–4976.

56.

WHO. Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance: Geneva: WHO. (Updated 10 July 2009. 3 October 2013.) Available from http://www.who.int/csr/disease/swineflu/guidance/surveillance/WHO_case_definition_swine_flu_2009_04_29.pdf?ua=1.

57.

WHO. WHO Informal Consultation on Surveillance of RSV on the Global Influenza Surveillance and Response System (GISRS) Platform 2015. (Updated December 2015. Accessed 1 December 2015.) Available from http://apps.who.int/iris/bitstream/10665/200762/1/WHO_HSE_PED_GIP_RSV_2015.01_eng.pdf.

58.

Penttinen

, Pebody

Influenza case definitions -optimising sensitivity and specificity.

Euro Surveill 2015; 20: 21148.

59.

Zhang

Surveillance of Respiratory Syncytial Viruses, WHO Consultation on RSV Vaccine Development, 23–24 March 2015, Starling Hotel Geneva. (Accessed 22 April 2015.) Available from http://www.who.int/immunization/research/meetings_workshops/RSVsurveillance_Zhang.pdf.

60.

Jiang

, Lee

V.J.

, Lim

W.Y.

Performance of case definitions for influenza surveillance.

Euro Surveill 2015; 20: 21145.

61.

Azzari

, Moriondo

, Indolf

Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease.

PLoS ONE 2010; 5: e9282.

62.

Iroh Tam

P.Y.

, Bernstein

, Ma

Blood culture in evaluation of pediatric community-acquired pneumonia: a systematic review and meta-analysis.

Hosp Pediatr 2015; 5: 324–336.

63.

Chaban

, Albert

, Links

M.G.

Characterization of the upper respiratory tract microbiomes of patients with pandemic H1N1 influenza.

PLoS ONE 2013; 8: e69559.

64.

Zhu

, Zhang

, Yu

The preventive effect of vaccine prophylaxis on severe respiratory syncytial virus infection: a meta-analysis.

Virol Sin 2015; 30: 371–378.